These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26758749)

  • 1. Price, value, and the cost of cancer drugs.
    Fojo T; Lo AW
    Lancet Oncol; 2016 Jan; 17(1):3-5. PubMed ID: 26758749
    [No Abstract]   [Full Text] [Related]  

  • 2. Indication-specific Drug Pricing - Simple in Theory, Complex in Reality.
    Kwon S
    Manag Care; 2018 May; 27(5):23-25. PubMed ID: 29763404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pricing in the Market for Anticancer Drugs.
    Howard DH; Bach PB; Berndt ER; Conti RM
    J Econ Perspect; 2015; 29(1):139-62. PubMed ID: 28441702
    [No Abstract]   [Full Text] [Related]  

  • 4. Indian drug maker cuts price of three cancer drugs by between 50% and 63%.
    Kay M
    BMJ; 2012 Nov; 345():e7786. PubMed ID: 23160905
    [No Abstract]   [Full Text] [Related]  

  • 5. In Cancer Care, Can We Afford To Hope?
    Hafner Z
    Manag Care; 2018 May; 27(5):31. PubMed ID: 29763406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering the High Cost of Cancer Drugs--II.
    Messori A; Fadda V; Trippoli S
    Mayo Clin Proc; 2016 Mar; 91(3):397-9. PubMed ID: 26944244
    [No Abstract]   [Full Text] [Related]  

  • 7. The high price of anticancer drugs: origins, implications, barriers, solutions.
    Prasad V; De Jesús K; Mailankody S
    Nat Rev Clin Oncol; 2017 Jun; 14(6):381-390. PubMed ID: 28290490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Running short.
    Mettner J
    Minn Med; 2011 Oct; 94(10):8-10. PubMed ID: 23256277
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer Drugs: An International Comparison of Postlicensing Price Inflation.
    Savage P; Mahmoud S; Patel Y; Kantarjian H
    J Oncol Pract; 2017 Jun; 13(6):e538-e542. PubMed ID: 28605615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual costs of cancer drugs in 15 European countries.
    van Harten WH; Wind A; de Paoli P; Saghatchian M; Oberst S
    Lancet Oncol; 2016 Jan; 17(1):18-20. PubMed ID: 26670093
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment.
    Lane JD; Friedberg MW; Bennett CL
    JAMA Oncol; 2016 Feb; 2(2):274-6. PubMed ID: 26658959
    [No Abstract]   [Full Text] [Related]  

  • 12. Why are cancer drugs so expensive in the United States, and what are the solutions?
    Kantarjian H; Rajkumar SV
    Mayo Clin Proc; 2015 Apr; 90(4):500-4. PubMed ID: 25792242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market spiral pricing of cancer drugs.
    Light DW; Kantarjian H
    Cancer; 2013 Nov; 119(22):3900-2. PubMed ID: 24002792
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost of Cancer Drugs: Something Has To Give.
    Bender E
    Manag Care; 2018 May; 27(5):18-22. PubMed ID: 29763403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all discounts on certain cancer drugs have disappeared.
    Thompson CA
    Am J Health Syst Pharm; 2015 Feb; 72(4):259-60. PubMed ID: 25631827
    [No Abstract]   [Full Text] [Related]  

  • 16. Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
    Cohen D
    BMJ; 2017 Apr; 357():j2097. PubMed ID: 28455308
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of a value based pricing index for new drugs in metastatic colorectal cancer.
    Dranitsaris G; Truter I; Lubbe MS
    Eur J Cancer; 2011 Jun; 47(9):1299-304. PubMed ID: 21493060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug assistance programs for the cancer patient.
    Mowad LZ; Richter SS
    Cancer Pract; 2000; 8(1):49-50. PubMed ID: 10732540
    [No Abstract]   [Full Text] [Related]  

  • 19. Value Tools Not in The Insurer Toolkit-Yet.
    Silverman E
    Manag Care; 2016 Oct; 25(10):16-17. PubMed ID: 28121538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer drug prices and the free-market forces.
    Kantarjian H; Zwelling L
    Cancer; 2013 Nov; 119(22):3903-5. PubMed ID: 24037953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.